Telegram Group & Telegram Channel
درمان بیماران مبتلا به MS با کمک نانومواد ساده‌تر می‌شود

🔹محققان نشان دادند چگونه دستگاه‌های کشت سلولی جدید مبتنی بر اکسید گرافن می‌توانند عملکرد ضدالتهابی سلول‌های سرکوبگر میلوئید (MDSCS) را حفظ کنند.

🔹عملکرد ضدالتهابی MDSCS می‌تواند هنگام جدا کردن سلول‌های ضدالتهابی برای درمان افراد مبتلا به بیماری اسکلروز بسیار مهم باشد.


@khabarsarasari



tg-me.com/KhabarSarasari/217883
Create:
Last Update:

درمان بیماران مبتلا به MS با کمک نانومواد ساده‌تر می‌شود

🔹محققان نشان دادند چگونه دستگاه‌های کشت سلولی جدید مبتنی بر اکسید گرافن می‌توانند عملکرد ضدالتهابی سلول‌های سرکوبگر میلوئید (MDSCS) را حفظ کنند.

🔹عملکرد ضدالتهابی MDSCS می‌تواند هنگام جدا کردن سلول‌های ضدالتهابی برای درمان افراد مبتلا به بیماری اسکلروز بسیار مهم باشد.


@khabarsarasari

BY کانال خبر سراسری




Share with your friend now:
tg-me.com/KhabarSarasari/217883

View MORE
Open in Telegram


کانال خبرسراسری Telegram | DID YOU KNOW?

Date: |

That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

کانال خبرسراسری from us


Telegram کانال خبر سراسری
FROM USA